Sabine D. Brookman-May/X
Sep 20, 2024, 12:09
Sabine D. Brookman-May: Interesting exchange in recurrent LG IR NMIBC
Sabine D. Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, shared a post on X by UroToday.com adding:
“Interesting exchange in recurrent LG IR NMIBC:
- Personalized treatment and Risk Stratification is the key
- Exploration of new treatment options
- High quality unitial TURBT is important
Quoting UroToday.com’s post below:
“To TURBT or Not to TURBT? Evaluating treatment options for recurrent low-grade, intermediate-risk bladder tumors.”
Source: Sabine D. Brookman-May/X and UroToday.com/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 29, 2024, 00:50
Dec 28, 2024, 18:47
Dec 28, 2024, 18:43
Dec 28, 2024, 18:21
Dec 28, 2024, 18:21
Dec 28, 2024, 18:19
Dec 28, 2024, 18:19